Brain Cancer Clinical Trials
The Ivy Brain Tumor Center’s precision medicine program is the first of its kind in neuro-oncology and reflects our commitment to always push the envelope for brain tumor patients around the world. Our unique Phase 0 clinical trials approach accelerates and streamlines the drug testing and approval process, allowing new drug combinations to be evaluated in patients within 10 days.
- Saves valuable time
- Personalizes the treatment
- Tests new drugs
If you are interested in learning whether you or a loved one may qualify for an Ivy Phase 0 clinical trial, please complete the form below. An Ivy Navigator will be in touch with you within two business days to discuss eligibility and answer any questions you may have.